2cureX AB (publ) Stock price Nasdaq Stockholm
Equities
SE0010468124
Biotechnology & Medical Research
Sales 2021 | 7.39M 690K | Sales 2022 | 3.37M 315K | Capitalization | 143M 13.4M |
---|---|---|---|---|---|
Net income 2021 | -18M -1.68M | Net income 2022 | -29M -2.71M | EV / Sales 2021 | 29.9 x |
Net cash position 2021 | 72.94M 6.81M | Net cash position 2022 | 44.89M 4.19M | EV / Sales 2022 | 29.3 x |
P/E ratio 2021 |
-14.6
x | P/E ratio 2022 |
-4.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 42.42% |
Latest transcript on 2cureX AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 21-01-31 | |
Grith Hagel
FOU | Founder | 65 | 05-12-31 |
Ole Thastrup
FOU | Founder | 71 | 05-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ole Thastrup
FOU | Founder | 71 | 05-12-31 |
Chairman | - | Nov. 13 |
1st Jan change | Capi. | |
---|---|---|
-6.65% | 12.54B | |
+82.29% | 4.14B | |
-14.23% | 2.34B | |
-23.73% | 2.51B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+7.42% | 840M | |
-11.75% | 548M | |
-34.49% | 466M |